These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 2901329

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of a long-acting somatostatin derivative SMS 201-995 (sandostatin) on glucose homeostasis in type I diabetes mellitus.
    Navascues I, Gil J, Pascau C, Senén D, del Pozo E, Serrano-Ríos M.
    Horm Res; 1988; 29(2-3):92-4. PubMed ID: 2900205
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduced postprandial hyperglycemia after subcutaneous injection of a somatostatin-analogue (SMS 201-995) in insulin-dependent diabetes mellitus.
    Spinas GA, Bock A, Keller U.
    Diabetes Care; 1985; 8(5):429-35. PubMed ID: 2865093
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin analog SMS 201-995 and insulin needs in insulin-dependent diabetic patients studied by means of an artificial pancreas.
    Rios MS, Navascues I, Saban J, Ordoñez A, Sevilla F, Del Pozo E.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1071-4. PubMed ID: 2876005
    [Abstract] [Full Text] [Related]

  • 6. Antidiabetic action of somatostatin--assessed by the artificial pancreas.
    Meissner C, Thum C, Beischer W, Winkler G, Schröder KE, Pfeiffer EF.
    Diabetes; 1975 Nov; 24(11):988-96. PubMed ID: 1102369
    [Abstract] [Full Text] [Related]

  • 7. Effects of somatostatin and SMS 201-995 on carbohydrate metabolism in normal man.
    Johnston DG, Davies RR, Turner SJ.
    Scand J Gastroenterol Suppl; 1986 Nov; 119():158-65. PubMed ID: 2876501
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-acting and selective suppression of growth hormone secretion by somatostatin analogue SMS 201-995 in acromegaly.
    Plewe G, Beyer J, Krause U, Neufeld M, del Pozo E.
    Lancet; 1984 Oct 06; 2(8406):782-4. PubMed ID: 6148524
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C, Kerner W, Maier V, Pfeiffer EF.
    Horm Metab Res Suppl; 1979 Oct 06; (8):115-8. PubMed ID: 395066
    [Abstract] [Full Text] [Related]

  • 14. Effects of SMS 201-995 on intermediary metabolism and endocrine status in normal and diabetic humans.
    Johnston DG, Davies RR, Alberti KG, Miller M, Turner SJ, Watson M, Orskov H.
    Am J Med; 1986 Dec 22; 81(6B):88-93. PubMed ID: 2879452
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of the somatostatin analogue octreotide on growth hormone secretion in insulin-dependent diabetics without residual insulin secretion.
    Wurzburger MI, Prelevic GM, Sonksen PH, Balint-Peric LA.
    Horm Metab Res; 1992 Jul 22; 24(7):329-32. PubMed ID: 1516889
    [Abstract] [Full Text] [Related]

  • 17. Metabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy.
    Osei K, O'Dorisio TM, Malarkey WB, Craig EL, Cataland S.
    Diabetes; 1989 Jun 22; 38(6):704-9. PubMed ID: 2656340
    [Abstract] [Full Text] [Related]

  • 18. Effects of somatostatin analogue SMS 201-995 in normal man.
    Davies RR, Miller M, Turner SJ, Goodship TH, Cook DB, Watson M, McGill A, Orskov H, Alberti KG, Johnston DG.
    Clin Endocrinol (Oxf); 1986 Jun 22; 24(6):665-74. PubMed ID: 2878747
    [Abstract] [Full Text] [Related]

  • 19. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
    Lamberts SW, Zweens M, Klijn JG, van Vroonhoven CC, Stefanko SZ, Del Pozo E.
    Clin Endocrinol (Oxf); 1986 Aug 22; 25(2):201-12. PubMed ID: 2878748
    [Abstract] [Full Text] [Related]

  • 20. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.
    Lamberts SW, Oosterom R, Neufeld M, del Pozo E.
    J Clin Endocrinol Metab; 1985 Jun 22; 60(6):1161-5. PubMed ID: 2860119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.